BTMD — biote Corp.

—
Nasdaq · Materials · Chemicals · CIK 1819253 ·
Last close
$0.99
Market Cap
$26.77M
52W High
$2.90
52W Low
$0.96
ADV30
106,102
Next earnings
2026-11-04
biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and meet other administrative requirements; inventory management software to facilitate ordering and inventory control; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support. It also sells dietary supplements under the Biote brand; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female patients. The company was founded in 2012 and is headquartered in Irving, Texas.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 43,334,000 29,331,000 2,487,000 407,000 101,696,000 8,851,000 159,294,000
Jun 2026 44,232,000 28,918,000 -3,508,000 -6,563,000 101,699,000 11,168,000 159,891,000
Mar 2026 44,935,000 30,953,000 3,166,000 2,277,000 89,032,000 5,320,000 136,987,000
Dec 2025 46,408,000 31,573,000 6,829,000 1,954,000 107,613,000 24,123,000 158,010,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$13,981,000
Investing CF
$-9,185,000
Financing CF
$-23,994,000
CapEx
$-9,185,000
Dividends Paid
$-1,167,000
Buybacks
$-7,225,000
EPS Diluted TTM
$-0.10
As of
2026-11-15

Balance + Analyst (yfinance extras)

Retained Earnings
$-49,135,000
Inventory
$17,765,000
Receivables
$9,578,000
ST Investments
—
EBIT TTM
$11,918,000
Pretax Income TTM
$3,174,000
Interest Exp TTM
$8,744,000
Analysts
5

Yahoo Snapshot (yfinance, live)

Total Revenue
$178,908,992
EBITDA
$12,356,000
Free Cash Flow
$-19,083,750
Enterprise Value
$155,636,368
Total Cash
$8,851,000
Total Debt
$127,825,000
Shares Out
27,040,089
Trailing EPS
$-0.07
Book Value
$-2.41
ROE
—
ROA
5.7%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 192,219,000 35,551,000 27,045,000 107,613,000 158,010,000 -58,539,000 35,194,000
Dec 2024 197,191,000 31,611,000 3,157,000 122,370,000 224,570,000 -105,928,000 45,243,000
Dec 2023 185,360,000 28,657,000 3,316,000 155,295,000 191,841,000 -29,397,000 26,883,000
Dec 2022 164,957,000 -60,722,000 -969,000 111,645,000 169,919,000 -44,459,000 -9,157,000

TTM Snapshot

Revenues TTM
$183,531,000
NetIncome TTM
$5,856,000
OpCashFlow TTM
—
Assets (Latest)
$101,699,000
Forward EPS
$0.34

Peers — same industry

TickerNameMarket CapLastDaily %
RAPH Raphael Pharmaceutical Inc. $30.47M $1.51 —
TANH TANTECH HOLDINGS LTD $30.71M $46.00 —
MRMD MARIMED INC. $23.22M $0.06 —
BLGO BIOLARGO, INC. $22.96M $0.07 —
LNZA LanzaTech Global, Inc. $32.59M $2.49 —

News headlines (Yahoo Finance, 1h cache)

biote: 3 Key Takeaways for Long-Term Investors
2026-11-16 22:50 · Yahoo
biote Corp. (BTMD) Q3 2026 Earnings Call Transcript
2026-11-05 18:50 · Yahoo
Biote Corp (BTMD) (Q3 2026) Earnings Call Highlights: Recall Recovery Lags, But Margin and ...
2026-11-05 05:13 · Yahoo
biote Corp. (BTMD) Tops Q3 Earnings Estimates
2026-11-04 21:50 · Yahoo
Biote Reports Third Quarter 2026 Financial Results
2026-11-04 21:11 · Yahoo
Biote Schedules Third Quarter 2026 Financial Results Release and Conference Call
2026-10-21 20:05 · Yahoo
Biote Corp (BTMD) (Q2 2026) Earnings Call Highlights: Navigating Recall Challenges and ...
2026-08-06 05:01 · Yahoo
biote Q2 Earnings Call Highlights
2026-08-05 23:04 · Yahoo
biote Q1 Earnings Call Highlights
2026-05-06 23:35 · Yahoo
biote Corp. Q1 2026 Earnings Call Summary
2026-05-07 12:30 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.